MEDINDIA
English
हिन्दी
Español
français
中文
COVID-19 in India: The weekly positive rate of the country currently stands at 0.14 percent, while the daily positive rate stands at 0.18 percent.
COVID-19 In India
The recovery of 198 patients in the last 24 hours took the cumulative tally to 4,41,42,989. Consequently, India's recovery rate stands at 98.80 percent.
Fluvoxamine: An OCD Drug can Prevent Covid-19 Patients from Hospitalization
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
Fluvoxamine has been proven among one such drug that could be used to treat COVID-19. Dozens of COVID patients showed no clinical deterioration in their symptoms when treated with a drug, fluvoxamine.
TOP INSIGHT
India has recorded 1 more COVID-19 related deaths, taking the national fatalities tally to 5,30,693.
With 1,11,304 vaccines administered in last 24 hours, India's COVID-19 vaccination coverage exceeded 220.05 crore.
Source-IANS
Omicron BF.7 COVID-19 Cases Increase in India
So far, three cases of the BF.7 strain, which is causing the current wave of COVID-19 infections in China, have been identified in India.
So far, three cases of the BF.7 strain, which is causing the current wave of COVID-19 infections in China, have been identified in India.
Nasal Antibodies Against COVID-19 Decline Nine Months After Infection
New research has highlighted the need for COVID-19 nasal spray vaccines capable of boosting local antibodies in the nose and lungs that prevent COVID-19.
New research has highlighted the need for COVID-19 nasal spray vaccines capable of boosting local antibodies in the nose and lungs that prevent COVID-19.
Dysphagia Has Emerged as 'Top' Clinical Symptom Among COVID-19 Patients
Dysphagia is a new symptom of COVID-19 during the SARS-CoV-2 Omicron variant wave.
Dysphagia is a new symptom of COVID-19 during the SARS-CoV-2 Omicron variant wave.
Email
